1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Medical Device Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Service
6.1 Testing Services
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Inspection Services
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Type
7.1 In-House
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Outsourced
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Testing Type
8.1 Biocompatibility Testing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Chemistry Testing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Bio-Burden Determination
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Anti-Microbial Activity and Sterility Testing
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Device Class
9.1 Class I
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Class II
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Class III
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Device Type
10.1 Implantable Medical Devices
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Non-Active Medical Devices
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 In-Vitro Diagnostic Medical Devices
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Ophthalmic Medical Devices
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 American Preclinical Services LLC
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Charles River Laboratories International Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Element Materials Technology
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Eurofins Scientific LLC
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Intertek Group Plc
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 North American Science Associates Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Pace Analytical Services LLC (LAB Holdings Inc.)
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 SGS SA
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Sterigenics U.S. LLC (Sotera Health LLC)
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Toxikon Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 TÜV Rheinland Aktiengesellschaft
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 TÜV SÜD Aktiengesellschaft
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.13 WuXi AppTec
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer